| Browse All

Bausch Health Companies Inc. (BHC)

Healthcare | Drug Manufacturers - Specialty & Generic | Laval, Canada | NYSE
5.90 USD +0.08 (1.375%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 5.88 -0.02 (-0.020%) ⇩ (April 17, 2026, 7:24 p.m. EDT)

Short-term: ★★★☆☆ | Long-term: ★★★★☆ | Dividends: ★☆☆☆☆
Hot Take | April 18, 2026, 11:42 p.m. EDT

Bausch Health represents a convergence of deep value and a catalyst-heavy dividend play, but it lacks the safety margin of a traditional value stock due to its severance overhang. Neither dividend nor margin of safety analysis, the current fundamentals are strong: Forward P/E is an anachronism, but the low trailing P/E and solid cash flows make it attractive. The stock is a core long-term position (4/5) but inappropriate for short-term trading (3/5) until the separation news settles and volatility compresses. The 11% recent gain and insider buying are early indicators of professional rotation into this neglected sector.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.055813
AutoARIMA0.056524
AutoETS0.056524
AutoTheta0.056561

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 57%
H-stat 2.30
Ljung-Box p 0.000
Jarque-Bera p 0.287
Excess Kurtosis -1.13
Attribute Value
Sector Healthcare
Ex Dividend Date 2010-11-09
Last Dividend Date 2010-11-09
Debt to Equity Ratio 5591.247
Revenue per Share 27.679
Market Cap 2,203,435,264
Trailing P/E 14.05
Forward P/E 1.46
Beta 0.40
Profit Margins 1.53%
Website https://www.bauschhealth.com

As of April 18, 2026, 11:42 p.m. EDT: Options flow indicates negligible near-term directional conviction. For expirations under 1 month (Apr 24, May 1), total open interest is extremely low, suggesting the market is not actively betting on immediate moves. IV skew in near-term puts is minimal (0.59 for 4/24 calls and puts). The bulk of the options activity is found in longer-dated ERVs (July, Oct, Jan). Notably, for longer tenors (especially July and beyond), there is a distinct skew towards Call Open Interest over Put Open Interest (e.g., Jan 15 calls have 15.6k OI vs 2.3k for puts). This suggests speculators are pricing in a neutral-to-positive drift over the next year, but near-term data supports a wait-and-see approach.


Dividend Data

Dividend History
Date Dividend Yield %
2010-11-10 1.000 3.901678
2010-08-30 0.095 0.435852
2010-05-28 0.095 0.660986
2010-03-04 0.090 0.613857
2009-11-30 0.090 0.659375
2009-08-28 0.090 0.749862
2009-05-13 0.090 0.886258
2009-03-06 0.375 3.753546
2008-12-19 0.375 4.652850
2008-08-21 0.375 4.339561
2008-05-20 0.375 3.724769
2008-03-25 0.375 4.294968
2007-11-16 0.375 2.879723
2007-08-16 0.375 2.946560
2007-05-18 0.375 2.057031
2007-03-22 0.375 2.367253
2007-01-08 0.500 3.374217
2006-11-20 0.125 1.035686
2006-08-16 0.125 1.127935
2006-05-19 0.125 0.714451
2006-04-05 0.125 0.725761
2005-11-28 0.500 3.173080
Additional Data
exDividendDate 2010-11-10
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 1.0
lastDividendDate 2010-11-10

Info Dump

Attribute Value
52 Week Change 0.25
Address1 2,150 St. ElzEar Boulevard West
All Time High 263.81
All Time Low 0.354167
Ask 5.98
Ask Size 5,000
Audit Risk 7
Average Analyst Rating 2.9 - Hold
Average Daily Volume10 Day 1,058,650
Average Daily Volume3 Month 2,056,130
Average Volume 2,056,130
Average Volume10Days 1,058,650
Beta 0.398
Bid 5.74
Bid Size 3,200
Board Risk 1
Book Value -1.495
City Laval
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 4
Country Canada
Crypto Tradeable 0
Currency USD
Current Price 5.9
Current Ratio 1.473
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 5.945
Day Low 5.83
Debt To Equity 5,591.247
Display Name Bausch Health Companies
Earnings Call Timestamp End 1,777,496,400
Earnings Call Timestamp Start 1,777,496,400
Earnings Timestamp 1,777,492,800
Earnings Timestamp End 1,777,492,800
Earnings Timestamp Start 1,777,492,800
Ebitda 3,400,000,000
Ebitda Margins 0.33119
Enterprise To Ebitda 6.732
Enterprise To Revenue 2.229
Enterprise Value 22,887,317,504
Eps Current Year 4.374
Eps Forward 4.046
Eps Trailing Twelve Months 0.42
Esg Populated 0
Ex Dividend Date 1,289,347,200
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 5.5662
Fifty Day Average Change 0.33380032
Fifty Day Average Change Percent 0.059969157
Fifty Two Week Change Percent 25.0
Fifty Two Week High 8.69
Fifty Two Week High Change -2.7899995
Fifty Two Week High Change Percent -0.32105863
Fifty Two Week Low 4.41
Fifty Two Week Low Change 1.4900002
Fifty Two Week Low Change Percent 0.33786854
Fifty Two Week Range 4.41 - 8.69
Financial Currency USD
First Trade Date Milliseconds 764,951,400,000
Five Year Avg Dividend Yield 6.52
Float Shares 258,515,467
Forward Eps 4.046
Forward P E 1.4582304
Free Cashflow 1,086,499,968
Full Exchange Name NYSE
Full Time Employees 20,300
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.70651
Gross Profits 7,253,000,192
Has Pre Post Market Data 1
Held Percent Insiders 0.10945
Held Percent Institutions 0.64888
Implied Shares Outstanding 373,463,589
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,289,347,200
Last Dividend Value 1.0
Last Fiscal Year End 1,767,139,200
Last Split Date 971,654,400
Last Split Factor 2:1
Long Business Summary Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Long Name Bausch Health Companies Inc.
Market us_market
Market Cap 2,203,435,264
Market State CLOSED
Max Age 86,400
Message Board Id finmb_345779
Most Recent Quarter 1,767,139,200
Net Income To Common 157,000,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 2,205,081,026
Number Of Analyst Opinions 7
Open 5.9
Operating Cashflow 1,400,000,000
Operating Margins 0.25787002
Overall Risk 4
Payout Ratio 0.0
Peg Ratio 0.01
Phone 514 744 6792
Post Market Change -0.01999998
Post Market Change Percent -0.33898273
Post Market Price 5.88
Post Market Time 1,776,468,241
Previous Close 5.82
Price Eps Current Year 1.3488797
Price Hint 2
Price To Book -3.9464884
Price To Sales Trailing12 Months 0.21463425
Profit Margins 0.0152900005
Quick Ratio 0.876
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key hold
Recommendation Mean 2.88889
Region US
Regular Market Change 0.0799999
Regular Market Change Percent 1.37457
Regular Market Day High 5.945
Regular Market Day Low 5.83
Regular Market Day Range 5.83 - 5.945
Regular Market Open 5.9
Regular Market Previous Close 5.82
Regular Market Price 5.9
Regular Market Time 1,776,456,002
Regular Market Volume 1,591,063
Return On Assets 0.051810004
Return On Equity 4.3636403
Revenue Growth 0.093
Revenue Per Share 27.679
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 5
Shares Outstanding 373,463,589
Shares Percent Shares Out 0.016
Shares Short 5,986,444
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 5,539,129
Short Name Bausch Health Companies Inc.
Short Percent Of Float 0.02
Short Ratio 2.67
Source Interval 15
State QC
Symbol BHC
Target High Price 10.0
Target Low Price 6.0
Target Mean Price 7.71429
Target Median Price 8.0
Total Cash 1,308,999,936
Total Cash Per Share 3.532
Total Debt 21,078,999,040
Total Revenue 10,266,000,384
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.42
Trailing P E 14.04762
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 6.41745
Two Hundred Day Average Change -0.51744986
Two Hundred Day Average Change Percent -0.080631696
Type Disp Equity
Volume 1,591,063
Website https://www.bauschhealth.com
Zip H7L 4A8